A Digital Therapeutic Intervention for Negative Symptoms of Schizophrenia

Дата публикации: 25-09-2026 00:00:00

This randomized clinical trial investigates the effectiveness and safety of CT-155, a smartphone-based digital therapeutic intervention, as an adjunct to pharmacotherapy for negative symptoms of schizophrenia.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Treatment Adherence and Health Care Utilization After a First Episode of Psychosis	0	7.77	24-09-2026
2	Digital Defocus Vision Training Using Virtual Reality for Myopia Control	0	9.14	27-08-2026
3	Support, Educate, Empower Program and Medication Adherence	0	4.95	01-04-2026
4	Mental health check-ins to smartphones may monitor suicide risk better than weekly therapy sessions	0	8.26	22-07-2026
5	Medications for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics	0	7.3	08-07-2026
6	Психофизиологические особенности стресс-фрустрационных реакций у пациентов с непсихотическими депрессивными расстройствами на фоне циталопрама	0	5	22-06-2026
7	Schizophrenia Spectrum and Dopaminergic Dysregulation	0	8.33	08-07-2026
8	A Culturally Embedded Augmented Reality Task as a Neurocognitive Biomarker of Executive Function in Schizophrenia	0	7	17-07-2026
9	Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care	0	5.63	15-10-2024
10	Highly Aspherical Lenslets for Myopia Control	0	6.82	20-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.14. Источник: jamanetwork.com.